Summary. Variations in the incidence rate of Type 1 (insulindependent) diabetes mellitus might relate to ethnic-specific genetic backgrounds. HLA-DQB 1 alleles were typed in 75 French diabetic children and 85 matched control children. Enzymatically-amplified DQB 1 exon 2 was hybridized with oligoprobes specific for the six most common alleles. Alleles coding for an Asp residue at position 57 in the DQ[~ chain are strongly negatively associated with Type 1 diabetes in the French population. Nevertheless, one of the diabetic children was an Asp 57 homozygote (DQB 1.2/3.1). Among alleles coding for a residue other than Asp at position 57, alleles 3.2 and 2 (Ala 57) are positively associated with diabetes but not allele 1.1 (Va157) which is less frequent in diabetic children than in control children. Heterozygosity for 2/3.2 alleles is the genotype most strongly associated with diabetes (Odds ratio = 52.9). Large comparative population studies will be necessary to determine whether the frequency of DQB 1 alleles positively associated with Type 1 diabetes (2 and 3.2) in a given ethnicity is related to its incidence rate in the same population.
diabetes in Europe varies from North to South. France has one of the lowest values [1], i. e. about six times lower than that reported in Finland [2] . HLA-DR 3 and DR 4 antigens have been identified as susceptibility markers for the disease in caucasian populations. DR and DQ loci are in strong linkage disequilibrium and several studies have suggested that only certain subsets of DR3 and DR 4 are increased in diabetic patients, namely those linked to DQB 2 and 3.2 alleles [3] . In North-American caucasians, Todd et al. [4] found that most haplotypes positively associated with Type 1 diabetes were related to genes encoding an amino acid other than aspartic acid at position 57 in the DQ[3 chain (Asp 57). They postulated that these non-Asp alleles (NA) of the DQB I gene were high risk markers for Type 1 diabetes as more than 90% of the patients were NA homozygotes [5] . Frequency of Asp (A) and NA alleles in various populations and its eventual relationship to the corresponding incidence of the disease are still poorly documented. In this study, we determined this frequency in a population of French diabetic children in comparison to a matched group of control children.
Subj ects and methods

Subjects
We studied 75 diabetic children randomly selected at the Diabetic Clinic of the H6pital Robert Debr6 (Paris, France). Mean age was 12.2 +_4.6 years and mean duration of the disease 2.9 + 3.4 years. Nine of the children were studied within the first year of the disease.
Diagnosis was ascertained by the occurrence of a ketotic or ketoacidotic episode. All patients were insulin-treated and of European caucasian extraction. The control group was made up of 85 school children recruited through systematic examinations at the Institut Rdgional pour la Sant6 (Tours, France). Ages ranged 7-15 years, none of the control group had symptoms of diabetes.
Methods
Genomic DNA was prepared from peripheral blood leucocytes by the guanidium chloride procedure [6] . DNA was digested with Bst EII (Boehringer, Mannheim, FRG) to specifically destroy the interfering DQB 2 sequence [7] . Exon 2 of the HLA-DQB 1 gene was amplified by the polymerase chain reaction (PCR) [8] . Hybridization was carried out as in [4] . The final wash for probe 1.2 was at 60 ~ Samples reacting with a single probe were tested for homozygosity by digesting the PCR-products with the restriction enzymes Hae III and Sma I. Primers and probes were prepared on a model 381A DNASynthesizer (Applied Biosystems, Foster City, Calif., USA) by the [3cyanoethyl-phosphoramidite method and purified by electrophoresis on a 20% acrylamide gel.
Statistical analysis
Chi-square test was used ~Eo compare allele frequencies, and odds ratios calculated to express the relative risk conferred by the different markers in the two populations. Figure I shows a histogram of the HLA-DQB 1 allele frequencies determined on 150 chromosomes in the diabetic group and 170 control chromosomes. Clearly, whereas A and NA allele frequencies are about equal in the control children, NA alleles are enriched in diabetic children as they are present on 92% of the chromosomes (Z2= 66.6, p < 0.001). This increased frequency is not equally due to all the NA alleles; only alleles 3.2 and 2, both corresponding to an Ala residue at position 57 in the DQ[3 chain, are positively associated with Type 1 diabetes (Z 2 = 74.5 and 39.3, p < 0.001; Odds ratios (OR) = 11.0 and 2.5, respectively). On the contrary, allele 1.1 (Val 57) is less frequent in diabetic children than in control children (Z2= 23, p <0.001; OR=0.5). The presence of A alleles is negatively associated with diabetes (Z=--29.3, p < 0.001; OR=0.1). Interestingly, unidentified alleles are more common in the control group (8.0% vs 1.3% ).
Results
HLA-DQB 1 allele frequencies
Distribution of HLA-DQB 1 allelic combinations
Distribution of the various DQB I allelic combinations in diabetic and control groups is reported in 
References Discussion
We have typed the alleles of the HLA-DQB 1 locus in a population of French diabetic children (n = 75) and in a matched control group (n = 85). Our results are in general agreement with the observation of Todd et al. [4] that alleles coding for an Asp residue at position 57 in the DQ[3 chain (A alleles) are strongly negatively associated with Type 1 diabetes in caucasian populations. Nevertheless, one of our diabetic children was an A/A homozygote (DQB 1.2/3.1). Indeed, the proposed protective effect of Asp 57 is not absolute as diabetic patients from Japanese and Chinese origins have now been found to be A/A homozygotes [9, 10] . More importantly, we find that among NA alleles, only those coding for Ala at position 57 (alleles 2 and 3.2) are positively associated with diabetes, whereas allele 1.1 (Va157) appears to be protective. As Val and Ala are both neutral aminoacids, the hypothesis of a direct implication of residue 57 in the pathogenesis of Type 1 diabetes should be regarded with caution. Some allelic combinations involve two alleles which individually exhibit an opposite association with the disease. Among these, A/NA heterozygosity is associated with a protective effect (OR = 0.23), but not the combination of allele 1.1 (Va157) with an other NA allele.
With the ASO probes used in this study, only the six most frequent DQB 1 alleles can be identified. Interestingly, unidentified alleles are much more common in control children than in diabetic children suggesting that allele diversity may be restricted in this latter group.
Whether frequency of the DQB i alleles positively associated with Type 1 diabetes (2 and 3.2) in a given ethnicity is related to the incidence rate of the disease in this population remains to be clarified. From our data and the only three surveys published to date [5, 9, 10] , this seems not to be the case: frequencies of NA/NA homozygotes in Japanese, Chinese, North-American and French normal subjects do not correlate to the known incidence figures in these countries. Large population-based studies are thus necessary to answer this question related to the genetic background of Type i diabetes.
